Beurs gesloten -
Japan Exchange
08:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
123
JPY
|
0,00%
|
|
-3,15%
|
-8,89%
|
Fiscaal tijdperk: december |
2020 Q3
|
2021 Q1
|
2021 Q3
|
2022 Q1
|
2022 Q3
|
2023 Q1
|
---|
Omzet
1 |
139
|
246
|
157
|
128
|
155
|
169
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-345
|
-155
|
-435
|
-486
|
-260
|
-225
|
Operationele Marge
|
-248,2%
|
-63,01%
|
-277,07%
|
-379,69%
|
-167,74%
|
-133,14%
|
Resultaat voor belastingen (EBT)
1 |
-352
|
-149
|
-434
|
-491
|
-255
|
-226
|
Nettowinst (verlies)
1 |
-351
|
-160
|
-434
|
-492
|
-256
|
-227
|
Nettomarge
|
-252,52%
|
-65,04%
|
-276,43%
|
-384,38%
|
-165,16%
|
-134,32%
|
WPA
2 |
-9,320
|
-4,000
|
-10,78
|
-11,66
|
-5,700
|
-4,700
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10-11-20
|
14-05-21
|
12-11-21
|
13-05-22
|
14-11-22
|
11-05-23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -8,89% | 43,53 mln. | | +1,51% | 42,75 mld. | | +8,57% | 41,34 mld. | | +49,22% | 41,61 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|